Research Paper Volume 16, Issue 2 pp 1581—1604
Identification of a basement membrane gene signature for predicting prognosis and estimating the tumor immune microenvironment in prostate cancer
Figure 5. Validate the predictive performance of BMRM in the MSKCC validation set. (A, B) Risk score plots from the MSKCC validation set. (C) Risk heat map of the two risk groups in the MSKCC validation set and correlation analysis of clinicopathological characteristics. (D) Kaplan-Meier analysis of RFS in the MSKCC validation set for PCa patients in both risk groups. (E) AUC shows the accuracy of BMRM in predicting 1-, 3-, and 5-year RFS in the MSKCC validation set.